- Home
- WWR vs SER Comparison
WWR vs SER Comparison
Compare WWR & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WWR
- SER
- Stock Information
- Founded
- WWR 1977
- SER 2017
- Country
- WWR United States
- SER United States
- Employees
- WWR N/A
- SER N/A
- Industry
- WWR Metal Mining
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- WWR Basic Materials
- SER Health Care
- Exchange
- WWR Nasdaq
- SER Nasdaq
- Market Cap
- WWR 48.0M
- SER 53.1M
- IPO Year
- WWR N/A
- SER 2018
- Fundamental
- Price
- WWR $0.78
- SER $4.59
- Analyst Decision
- WWR Strong Buy
- SER Strong Buy
- Analyst Count
- WWR 2
- SER 2
- Target Price
- WWR $2.00
- SER $13.00
- AVG Volume (30 Days)
- WWR 1.2M
- SER 339.1K
- Earning Date
- WWR 11-14-2025
- SER 11-11-2025
- Dividend Yield
- WWR N/A
- SER N/A
- EPS Growth
- WWR N/A
- SER N/A
- EPS
- WWR N/A
- SER N/A
- Revenue
- WWR N/A
- SER $130,000.00
- Revenue This Year
- WWR N/A
- SER $17.23
- Revenue Next Year
- WWR N/A
- SER N/A
- P/E Ratio
- WWR N/A
- SER N/A
- Revenue Growth
- WWR N/A
- SER N/A
- 52 Week Low
- WWR $0.45
- SER $3.81
- 52 Week High
- WWR $1.32
- SER $10.28
- Technical
- Relative Strength Index (RSI)
- WWR 57.76
- SER 35.56
- Support Level
- WWR $0.66
- SER $4.90
- Resistance Level
- WWR $0.79
- SER $5.25
- Average True Range (ATR)
- WWR 0.05
- SER 0.27
- MACD
- WWR 0.00
- SER -0.05
- Stochastic Oscillator
- WWR 69.44
- SER 2.24
About WWR Westwater Resources Inc.
Westwater Resources Inc focused on developing battery-grade natural graphite materials. The company is having one project which is the Westwater's coosa project which is currently used for the mining and extraction of graphite.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.